Yim et al. previously demonstrated that in breast cancer cells, FRK acts by inhibiting the PI3K/Akt signaling via the phosphorylation and stabilization of the tumor suppressor PTEN [8]. This evidence concerns the gene AKT1 and breast carcinoma.